Advertisement
Original article| Volume 34, ISSUE 1-2, P3-12, July 01, 1993

Download started.

Ok

Autonomic effects of clozapine in schizophrenia: Comparison with placebo and fluphenazine

  • Theodore P. Zahn
    Correspondence
    Address reprint requests to Dr. Theodore P. Zahn, Bldg. 10, Rm 4C110, National Institute of Health, Bethesda, MD 20892 USA.
    Affiliations
    From the Laboratory of Psychology and Psychopathology, National Institute of Mental Health, Bethesda, MD, USA
    Search for articles by this author
  • David Pickar
    Affiliations
    Experimental Therapeutics Branch, National Institute of Mental Health, Bethesda, MD, USA
    Search for articles by this author
DOI:https://doi.org/10.1016/0006-3223(93)90250-H
Autonomic effects of clozapine in schizophrenia: Comparison with placebo and fluphenazine
Previous ArticleValium, histamine, and neural networks
Next ArticleAdverse reactions to aspartame: Double-blind challenge in patients from a vulnerable population
      This paper is only available as a PDF. To read, Please Download here.

      Abstract

      Periphercal indicators of autonomic nervous system activity, including electrodermal activity and heart rate, were studied in 25 chronic schizophrenic patients given clinical trials of clozapine, a standard neuroleptic (fluphenazine), and placebo. The protocol included a rest period, presentation of nonsignal tones, and a reaction time task. Clozapine markedly attenuated electrodermal base levels and both phasic and tonic electrodermal responsivity compared to placebo, and somewhat less consistently compared to fluphenazine. Both electrodermal and vasoconstrictive orienting responses to tones were reduced. Elevated heart rate and reduced heart rate variability were also observed in patients taking clozapine. Many of these effects can be accounted for by clozapine's anticholinergic and antihistaminic properties. There was evidence that a smaller autonomic response to the mild stress of task performance and larger heart rate responses to nonsignal tones on the alternate treatments were predictive of a good clinical response to clozapine. These results suggest that when on alternate treatments good clozapine responders show more psychophysiological signs of pathology than clinical nonresponders.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • Albus M.
        • Zahn T.P.
        • Breier A.
        Anxiogenic effects of yohimbine: I. Behavioral, physiological and biochemical measures.
        Eur Arch Psychiat Clin Neurosci. 1992; 241: 337-344
        • Andreasen N.C.
        Negative symptoms in schizophrenia: Definition and reliability.
        Arch Gen Psychiatry. 1982; 39: 784-794
        • Baldessarini R.J.
        • Frankenburg F.R.
        Clozapine: A novel antipsychotic agent.
        N Engl J Med. 1991; 324: 746-754
        • Bernstein A.S.
        • Frith C.D.
        • Gruzelier J.H.
        • et al.
        An analysis of the skin conductance orienting response in samples of American, British, and German schizophrenics.
        Biol Psychol. 1982; 14: 155-211
        • Bernstein A.S.
        • Riedel J.A.
        • Graae F.
        • et al.
        Schizophrenia is associated with altered orienting activity; depression with electrodermal (cholinergic?) deficit and normal orienting response.
        J Abnorm Psychol. 1988; 97: 3-12
        • Bunney W.E.
        • Hamburg D.A.
        Methods for reliable longitudinal observation of behavior.
        Arch Gen Psychiatry. 1963; 20: 280-294
        • Green M.F.
        • Nuechterlein K.H.
        • Satz P.
        The relationship of symptomatology and medication to electrodermal activity in schizophrenia.
        Psychophysiology. 1989; 26: 148-157
        • Kane J.
        • Honigfeld G.
        • Singer J.
        • Meltzer H.
        Clozapine for the treatment-resistant schizophrenic: A double-blind comparison with chlorpromazine.
        Arch Gen Psychiatry. 1988; 45: 789-796
        • Leiderman P.H.
        • Shapiro D.
        Application of a time series statistic to physiology and psychology.
        Science. 1962; 138: 141-142
        • Meltzer H.Y.
        Clinical studies on the mechanism of action of clozapine: the dopamine-serotonin hypothesis of schizophrenia.
        Psychopharmacology (Berl). 1989; 99 (suppl): 18-27
        • Meltzer H.Y.
        Clozapine: Mechanism of action in relation to its clinical advantages.
        in: Kales A. Stefanos C.N. Talbott J.A. Recent Advances in Schizophrenia. Springer, New York1989: 237-256
        • Overall J.E.
        • Hollister L.E.
        • Pichot P.
        Major psychiatric disorders: A four dimensional model.
        Arch Gen Psychiatry. 1967; 24: 146-151
        • Pickar D.
        • Owen R.R.
        • Litman R.E.
        • Konicki P.E.
        • Gutierrez R.
        • Rapaport M.H.
        Clinical and biologic response to clozapine in patients with schizophrenia: Crossover comparison with fluphenazine.
        Arch Gen Psychiatry. 1992; 49: 345-353
        • Spohn H.E.
        • Coyne L.
        • Wilson J.K.
        • Hayes K.
        Skin-conductance orienting response in chronic schizophrenics: the role of neuroleptics.
        J Abnorm Psychol. 1989; 98: 478-486
        • Spohn H.E.
        • Lacoursiere R.B.
        • Thompson K.
        • Coyne L.
        Phenothiazine effects on psychological and psychophysiological dysfunction in chronic schizophrenics.
        Arch Gen Psychiatry. 1977; 34: 633-644
        • Zahn T.P.
        • Carpenter W.T.J.
        • McGlashan T.H.
        Autonomic nervous system activity in acute schizophrenia: I. Method and comparison with normal controls.
        Arch Gen Psychiatry. 1981; 38: 251-258
        • Zahn T.P.
        • Carpenter W.T.J.
        • McGlashan T.H.
        Autonomic nervous system activity in acute schizophrenia: II. Relationships to short-term prognosis and clinical state.
        Arch Gen Psychiatry. 1981; 38: 260-266
        • Zahn T.P.
        • Frith C.D.
        • Steinhauer S.R.
        Autonomic functioning in schizophrenia: Electrodermal activity, heart rate, pupillography.
        in: Handbook of Schizophrenia, Vol. 5: Neuropsychology, Psychophysiology and Information Processing. Elsevier, Amsterdam1991: 185-224

      Article info

      Publication history

      Received in revised form: March 31, 1993
      Received: October 3, 1992

      Identification

      DOI: https://doi.org/10.1016/0006-3223(93)90250-H

      Copyright

      © 1993 Published by Elsevier Inc.

      ScienceDirect

      Access this article on ScienceDirect

      The content on this site is intended for healthcare professionals.


      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the Cookie Preference Center for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties.


      RELX